| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 10 1033-1040, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
R Maneckjee and JD Minna
Simmons Cancer Center, Department of Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8590.
Previously, we have shown that opioids acting via specific receptors inhibit the growth of human lung cancer cells while nicotine, acting through nicotinic acetylcholine receptors, reverses this inhibition. Therefore, we studied the role of apoptosis in these processes. Treatment of human lung cancer cells with 0.1-1 microM morphine or methadone resulted in morphological changes and cleavage of DNA into nucleosome-sized fragments characteristic of apoptosis. Quantitation of DNA fragmentation showed that a dose-dependent increase occurred within 2 h of opioid treatment and was blocked by the antagonist naloxone. The apoptotic effect of opioids was suppressed by nicotine, while the nicotinic acetylcholine receptor antagonists, hexamethonium and decamethonium, reversed this suppression. In contrast, sphingosine, a protein kinase C inhibitor, caused significant DNA fragmentation which was not suppressed by nicotine. Unexpectedly, the combination of hexamethonium and opioids or hexamethonium and nicotine stimulated apoptosis. We found that nicotine, like phorbol 12-myristate 13-acetate, increased total protein kinase C (PKC) activity, while morphine and sphingosine decreased PKC activity, and nicotine reversed morphine inhibition of PKC activity. In contrast, methadone unexpectedly increased PKC activity. These results indicate that engagement of opioid receptors in human lung cancer cells induces apoptosis, while engagement of nicotine receptors suppresses apoptosis, which in some cases appear to be working through a PKC pathway. They also suggest complexities in the system where blockade of C6 or C10 nicotinic receptors can lead to facilitation of apoptosis. These findings suggest new strategies for treatment and prevention of cancer using opioids or nicotine receptors antagonists and are consistent with the idea that nicotine functions as a tumor promoter.
This article has been cited by other articles:
![]() |
P. Liu, H. G. Vikis, D. Wang, Y. Lu, Y. Wang, A. G. Schwartz, S. M. Pinney, P. Yang, M. de Andrade, G. M. Petersen, et al. Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer J Natl Cancer Inst, September 17, 2008; 100(18): 1326 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.-l. Lam, L. Girard, R. Ramirez, W.-s. Chau, W.-s. Suen, S. Sheridan, V. P.C. Tin, L.-p. Chung, M. P. Wong, J. W. Shay, et al. Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers Cancer Res., May 15, 2007; 67(10): 4638 - 4647. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Song, H. S. Sekhon, A. Lu, J. Arredondo, D. Sauer, C. Gravett, G. P. Mark, S. A. Grando, and E. R. Spindel M3 Muscarinic Receptor Antagonists Inhibit Small Cell Lung Carcinoma Growth and Mitogen-Activated Protein Kinase Phosphorylation Induced by Acetylcholine Secretion Cancer Res., April 15, 2007; 67(8): 3936 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Madar, B. Bencherif, J. Lever, R. F. Heitmiller, S. C. Yang, M. Brock, J. Brahmer, H. Ravert, R. Dannals, and J. J. Frost Imaging {delta}- and {micro}-Opioid Receptors by PET in Lung Carcinoma Patients J. Nucl. Med., February 1, 2007; 48(2): 207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arredondo, A. I. Chernyavsky, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of {alpha}7 nicotinic receptor in oral keratinocytes FASEB J, October 1, 2006; 20(12): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Gritz, C. Dresler, and L. Sarna Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, M. Chu, T. Abbeyquaye, and C.-Y. Chen Persistent Nicotine Treatment Potentiates Amplification of the Dihydrofolate Reductase Gene in Rat Lung Epithelial Cells as a Consequence of Ras Activation J. Biol. Chem., August 26, 2005; 280(34): 30422 - 30431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tsurutani, S.S. Castillo, J. Brognard, C. A. Granville, C. Zhang, J. J. Gills, J. Sayyah, and P. A. Dennis Tobacco components stimulate Akt-dependent proliferation and NF{kappa}B-dependent survival in lung cancer cells Carcinogenesis, July 1, 2005; 26(7): 1182 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arredondo, A. I. Chernyavsky, L. M. Marubio, A. L. Beaudet, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando Receptor-Mediated Tobacco Toxicity: Regulation of Gene Expression through {alpha}3{beta}2 Nicotinic Receptor in Oral Epithelial Cells Am. J. Pathol., February 1, 2005; 166(2): 597 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Chen, P. Y. Law, and H. H. Loh Inhibition of Akt/Protein Kinase B Signaling by Naltrindole in Small Cell Lung Cancer Cells Cancer Res., December 1, 2004; 64(23): 8723 - 8730. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Y. Shin, W. K.K. Wu, Y.-N. Ye, W. H.L. So, M. W.L. Koo, E. S.L. Liu, J.-C. Luo, and C.-H. Cho Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2 Carcinogenesis, December 1, 2004; 25(12): 2487 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Argentin and R. Cicchetti Genotoxic and Antiapoptotic Effect of Nicotine on Human Gingival Fibroblasts Toxicol. Sci., May 1, 2004; 79(1): 75 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Trombino, A. Cesario, S. Margaritora, P. Granone, G. Motta, C. Falugi, and P. Russo {alpha}7-Nicotinic Acetylcholine Receptors Affect Growth Regulation of Human Mesothelioma Cells: Role of Mitogen-Activated Protein Kinase Pathway Cancer Res., January 1, 2004; 64(1): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tegeder, S. Grosch, A. Schmidtko, A. Haussler, H. Schmidt, E. Niederberger, K. Scholich, and G. Geisslinger G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation Cancer Res., April 15, 2003; 63(8): 1846 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mai, W. S. May, F. Gao, Z. Jin, and X. Deng A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis J. Biol. Chem., January 10, 2003; 278(3): 1886 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mao, B. Sung, R.-R. Ji, and G. Lim Neuronal Apoptosis Associated with Morphine Tolerance: Evidence for an Opioid-Induced Neurotoxic Mechanism J. Neurosci., September 1, 2002; 22(17): 7650 - 7661. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueki, M. Toyota, H. Skinner, K. M. Walter, C. J. Yeo, J.-P. J. Issa, R. H. Hruban, and M. Goggins Identification and Characterization of Differentially Methylated CpG Islands in Pancreatic Carcinoma Cancer Res., December 1, 2001; 61(23): 8540 - 8546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hakki, K. Pennypacker, S. Eidizadeh, H. Friedman, and S. Pross Nicotine Inhibition of Apoptosis in Murine Immune Cells Experimental Biology and Medicine, November 1, 2001; 226(10): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chatzaki, A. Makrigiannakis, A.N. Margioris, E. Kouimtzoglou, and A. Gravanis The Fas/FasL apoptotic pathway is involved in {kappa}-opioid-induced apoptosis of human endometrial stromal cells Mol. Hum. Reprod., September 1, 2001; 7(9): 867 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Cao, K. Mortensen, D. Tornehave, and L.-I. Larsson Apoptosis in Rat Gastric Antrum: Evidence That Regulation by Food Intake Depends on Nitric Oxide Synthase J. Histochem. Cytochem., January 1, 2000; 48(1): 123 - 132. [Abstract] [Full Text] |
||||
![]() |
K. M. Fong, Y. Sekido, and J. D. Minna MOLECULAR PATHOGENESIS OF LUNG CANCER J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |